Amarin Corp. Plc (AMRN)
13.82
+0.16
(+1.17%)
USD |
NASDAQ |
Dec 24, 12:30
Amarin SG&A Expense (TTM): 121.28M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Trinity Biotech Plc | 24.41M |
| Jazz Pharmaceuticals Plc | 1.772B |
| DBV Technologies SA | 28.71M |
| Cellectis SA | 19.93M |
| Akari Therapeutics Plc | 10.20M |